Latest Insider Transactions at Applied Dna Sciences Inc (APDN)
This section provides a real-time view of insider transactions for Applied Dna Sciences Inc (APDN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of APPLIED DNA SCIENCES INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of APPLIED DNA SCIENCES INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 17
2025
|
Clay Shorrock Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
18,691
+49.99%
|
-
|
|
Oct 17
2025
|
Judith Murrah Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,691
+50.0%
|
-
|
|
Oct 17
2025
|
Yacov A Shamash Director |
BUY
Grant, award, or other acquisition
|
Direct |
22,511
+50.0%
|
-
|
|
Oct 17
2025
|
Elizabeth M. Ferguson Director |
BUY
Grant, award, or other acquisition
|
Direct |
22,511
+50.0%
|
-
|
|
Oct 17
2025
|
Beth Jantzen Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
18,691
+50.0%
|
-
|
|
Oct 17
2025
|
Robert B Catell Director |
BUY
Grant, award, or other acquisition
|
Direct |
22,511
+50.0%
|
-
|
|
Oct 17
2025
|
Joseph D. Ceccoli Director |
BUY
Grant, award, or other acquisition
|
Direct |
22,511
+50.0%
|
-
|
|
Mar 23
2023
|
Judith Murrah Director |
BUY
Grant, award, or other acquisition
|
Direct |
99,306
+49.37%
|
-
|
|
Mar 23
2023
|
Clay Shorrock Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
91,667
+50.0%
|
-
|
|
Mar 23
2023
|
Beth Jantzen Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
91,667
+49.98%
|
-
|
|
Mar 10
2021
|
Scott L Anchin Director |
SELL
Open market or private sale
|
Direct |
13,049
-42.92%
|
$104,392
$8.48 P/Share
|
|
Mar 05
2021
|
Scott L Anchin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
13,049
+35.85%
|
$52,196
$4.35 P/Share
|